These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9542874)

  • 21. The menace of substandard drugs.
    Roy J
    World Health Forum; 1994; 15(4):406-7. PubMed ID: 7999239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manufacturing and standardizing allergen extracts in Europe.
    Larsen JN; Houghton CG; Løwenstein H; Lombardero M
    Clin Allergy Immunol; 2004; 18():433-55. PubMed ID: 15042928
    [No Abstract]   [Full Text] [Related]  

  • 23. [European registration of drugs].
    Juillet Y
    Therapie; 1996; 51(4):449-52. PubMed ID: 8953829
    [No Abstract]   [Full Text] [Related]  

  • 24. [Falsified drugs hardly a threat against public health in Sweden].
    Pehrson P
    Lakartidningen; 2007 Mar 14-20; 104(11):886; author reply 886. PubMed ID: 17447588
    [No Abstract]   [Full Text] [Related]  

  • 25. [Orphan drugs: some legal, ethical and economics aspects].
    Pabst JY
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):387-96. PubMed ID: 11567205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Too many drugs?
    Halberstam MJ
    Forum Med; 1979 Mar; 2(3):170-6 concl. PubMed ID: 10316794
    [No Abstract]   [Full Text] [Related]  

  • 27. [Falsified drugs--a hidden problem in health care].
    Cronlund A
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1166. PubMed ID: 17472109
    [No Abstract]   [Full Text] [Related]  

  • 28. [Registration of side effects of drugs in Denmark].
    Pedersen A
    Ugeskr Laeger; 1968 May; 130(19):823-7. PubMed ID: 5699674
    [No Abstract]   [Full Text] [Related]  

  • 29. Principles of drug regulations in Yugoslavia.
    Zlatic S; Vrhovac B
    Int J Clin Pharmacol; 1973 Apr; 7(2):180-2. PubMed ID: 4731285
    [No Abstract]   [Full Text] [Related]  

  • 30. [Quality control].
    Polderman J
    Pharm Weekbl; 1968 Apr; 103(17):465-71. PubMed ID: 5665058
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical counterfeiting.
    Deisingh AK
    Analyst; 2005 Mar; 130(3):271-9. PubMed ID: 15724152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Control of the quality of drugs in pharmacies].
    Kuleshova MI; Chichiro VE
    Farmatsiia; 1967; 16(5):51-6. PubMed ID: 5612630
    [No Abstract]   [Full Text] [Related]  

  • 33. [Measures against falsified drugs].
    Andersson JR; Bengtsson F
    Lakartidningen; 2010 Mar 31-Apr 13; 107(13-14):927. PubMed ID: 20437657
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacology--basis of drug testing by the physician].
    Herken H
    Internist (Berl); 1973 Jan; 14(1):6-13. PubMed ID: 4576797
    [No Abstract]   [Full Text] [Related]  

  • 35. [Course and problems of clinical drug testing].
    Neuhaus GA
    Internist (Berl); 1973 Jan; 14(1):14-8. PubMed ID: 4576791
    [No Abstract]   [Full Text] [Related]  

  • 36. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic tasks concerning improvement of drugs control].
    Kliuev MA
    Farmatsiia; 1967; 16(2):3-9. PubMed ID: 5611767
    [No Abstract]   [Full Text] [Related]  

  • 39. Basis for the assurance of safety, quality and efficacy of medicines in Ireland.
    Scott AI
    Ir Med J; 1985 Dec; 78(12):361-4. PubMed ID: 4086258
    [No Abstract]   [Full Text] [Related]  

  • 40. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.